We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!
0
Signin
countryflagUS

18889881171

MSFT 409.6999 -1.5286% AAPL 222.71 -1.8034% NVDA 128.3057 2.7103% GOOGL 163.14 -2.3465% GOOG 164.6592 -2.3142% AMZN 180.47 -3.2384% META 585.16 -1.8089% AVGO 175.79 -0.4812% TSLA 241.6955 -3.3527% TSM 183.57 1.3303% LLY 899.35 1.374% V 273.29 -1.6695% JPM 209.74 -0.7007% UNH 584.575 -1.1206% NVO 117.48 2.05% WMT 79.45 -1.8409% LVMUY 148.82 1.4451% XOM 125.47 0.5127% LVMHF 745.0 1.5609% MA 491.24 -1.298%

Guardion Health Sciences Inc

Healthcare US GHSI

3.25USD
-0.05(1.52%)

Last update at 2024-10-07T18:51:00Z

Day Range

3.233.40
LowHigh

52 Week Range

5.0110.75
LowHigh

Fundamentals

  • Previous Close 3.30
  • Market Cap11.88M
  • Volume73324
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.56676M
  • Revenue TTM12.06M
  • Revenue Per Share TTM9.47
  • Gross Profit TTM 4.52M
  • Diluted EPS TTM-4.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -14.92223M -24.74501M -8.57166M -10.87831M -7.76741M
Minority interest - - - - 0.00000M
Net income -30.27713M -24.74501M -8.57893M -11.13667M -7.76741M
Selling general administrative 9.58M 11.20M 6.83M 7.43M 4.93M
Selling and marketing expenses 2.07M 2.32M 1.45M 1.87M 1.52M
Gross profit 4.52M 3.11M -0.05679M 0.56M 0.54M
Reconciled depreciation 1.25M 0.91M 0.22M 0.63M 0.30M
Ebit 0.43M -10.48338M -8.55173M -8.93342M -6.14372M
Ebitda 1.68M -9.57403M -8.28268M -8.72359M -5.84805M
Depreciation and amortization 1.25M 0.91M 0.27M 0.21M 0.30M
Non operating income net other - - -0.01265M - -
Operating income 0.43M -10.48338M -8.55173M -8.93342M -6.14372M
Other operating expenses 18.37M 17.72M 10.39M 9.84M 7.09M
Interest expense 15.35M 0.00180M 0.00727M 0.26M 0.00229M
Tax provision - - - - -
Interest income 0.15M 0.00180M - 0.03M 1.62M
Net interest income 0.15M 0.00180M -0.00727M -0.67432M -0.00229M
Extraordinary items - - - - 0.00000M
Non recurring - - 0.05M - 0.00000M
Other items - - - - 0.00000M
Income tax expense 15.35M 14.26M 0.00727M 0.26M -1.62140M
Total revenue 11.05M 7.23M 1.89M 0.90M 0.94M
Total operating expenses 11.84M 13.59M 8.45M 9.50M 6.69M
Cost of revenue 6.53M 4.12M 1.95M 0.34M 0.40M
Total other income expense net -15.35491M -14.26163M -0.01993M -1.94489M -1.62140M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -14.92223M -24.74501M -8.57166M -10.87831M -7.76741M
Net income applicable to common shares -15.86381M -24.74501M -8.57166M -10.87831M -7.76741M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 11.92M 21.69M 23.46M 9.86M 12.88M
Intangible assets - - 11.26M 0.05M 0.05M
Earning assets - - - - -
Other current assets 0.57M 0.69M 1.20M 0.18M 0.36M
Total liab 3.77M 8.52M 1.16M 1.35M 0.84M
Total stockholder equity 8.15M 13.17M 22.30M 8.52M 12.03M
Deferred long term liab - - - - -
Other current liab 0.70M 2.49M 0.90M 0.03M 0.01M
Common stock 0.00128M 0.00127M 0.02M 0.02M 0.07M
Capital stock 0.00128M 5.25M 0.02M 0.02M 0.07M
Retained earnings -93.56627M -93.72430M -78.80207M -54.08333M -45.51167M
Other liab - 4.51M - - -
Good will - - - - 0.00000M
Other assets - - - 0.01M 0.01M
Cash 6.36M 10.66M 4.09M 8.52M 11.12M
Cash and equivalents - - - - -
Total current liabilities 1.32M 4.01M 1.16M 1.07M 0.41M
Current deferred revenue - - - 0.28M 0.12M
Net debt -6.35965M -10.65168M -4.06790M -8.08398M -10.52919M
Short term debt - 0.00381M 0.02M 0.16M 0.15M
Short long term debt - - - - -
Short long term debt total - 0.00381M 0.03M 0.43M 0.59M
Other stockholder equity 101.71M 101.64M 101.08M 62.58M 57.47M
Property plant equipment - 0.05M 0.14M 0.70M 0.95M
Total current assets 11.88M 21.64M 12.07M 9.09M 11.87M
Long term investments - - - - -
Net tangible assets - 7.92M 11.04M 8.47M 11.98M
Short term investments - 0.00000M 5.00M - -
Net receivables 2.27M 1.92M 1.41M 0.01M 0.08M
Long term debt - - - - -
Inventory 2.68M 3.12M 0.37M 0.38M 0.31M
Accounts payable 0.61M 1.52M 0.24M 0.61M 0.13M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -11.91818M - - - -0.38060M
Additional paid in capital - - - - -
Common stock total equity - - - 0.02M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -54.08333M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.01M 0.01M
Deferred long term asset charges - - - - -
Non current assets total 0.03M 0.05M 11.39M 0.77M 1.01M
Capital lease obligations 0.00000M 0.00381M 0.03M 0.43M 0.59M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 4.99M -31.01140M -0.03473M -0.17108M -0.31024M
Change to liabilities 1.28M -0.68070M 0.48M -0.01424M 0.10M
Total cashflows from investing activities 4.99M -31.01140M -0.03473M -0.17108M -0.31024M
Net borrowings - - - 0.25M -0.17667M
Total cash from financing activities 14.27M 37.23M 5.45M 16.65M 0.42M
Change to operating activities -0.26747M -0.58599M -0.11635M -0.41520M 0.14M
Net income -14.92223M -24.74501M -8.57166M -10.87831M -7.76741M
Change in cash 11.81M -4.42481M -2.59677M 10.44M -4.06428M
Begin period cash flow 4.09M 8.52M 11.12M 0.67M 4.74M
End period cash flow 15.91M 4.09M 8.52M 11.12M 0.67M
Total cash from operating activities -7.44681M -10.64442M -8.01393M -6.03000M -4.17383M
Issuance of capital stock 13.14M 33.66M 0.00000M 16.22M 0.85M
Depreciation 1.25M 0.91M 0.22M 0.63M 0.30M
Other cashflows from investing activities - - 0.00600M - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory -2.80734M 0.45M -0.72880M 0.05M -0.20327M
Change to account receivables -0.09429M 0.38M 0.07M -0.05013M 0.04M
Sale purchase of stock -0.00903M -70.95256M 5.45M 16.40M 0.87M
Other cashflows from financing activities 5.44M 3.57M 5.45M 0.52M -0.39967M
Change to netincome 8.12M 13.63M 0.64M 4.41M 3.22M
Capital expenditures 0.00557M 0.07M 0.04M 0.17M 0.31M
Change receivables - - 0.08M - -
Cash flows other operating - - -1.06355M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -2.59677M - -
Change in working capital -1.89255M -0.43689M -0.29889M -0.43253M 0.08M
Stock based compensation - 0.00000M -0.39681M 2.72M 1.60M
Other non cash items 8.12M 13.63M -0.94094M 0.67M 1.62M
Free cash flow -7.45238M -10.71901M -8.05466M -6.20108M -4.48407M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GHSI
Guardion Health Sciences Inc		 -0.05 1.52% 3.25 - - 0.83 1.25 0.39 -1.2093
ZTS
Zoetis Inc		 -3.095 1.63% 186.94 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.74 2.17% 33.33 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.745 1.62% 167.00 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.13 0.90% 14.30 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Guardion Health Sciences Inc

2925 Richmond Avenue, Houston, TX, United States, 77098

Key Executives

Name Title Year Born
Mr. Robert Neal Weingarten Independent Chairman & Sec. 1952
Mr. Bret D. Scholtes Pres, CEO & Director 1970
Mr. Craig J. Sheehan Chief Commercial Officer 1971
Mr. Jeffrey Benjamin Chief Accounting Officer 1965
Mr. Robert Neal Weingarten Independent Chairman & Secretary 1952
Ms. Janet Hall President & CEO 1959
Ms. Katie Cox Chief Accounting Officer 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.